National Engineering Research Center for Beijing Biochip Technology
The National Engineering Research Center for Beijing Biochip Technology (NERCBBT), founded under the approval of the National Development and Reform Commission (NDRC), is a key national center for advanced research in biochip and related technologies. It has the strongest R&D capability and occupies the largest market share of biochips in China. On September 30, 2000, Tsinghua University, together with Huazhong University of Science and Technology, the Chinese Academy of Medical Sciences, and the Academy of Military Medical Sciences, built the National Engineering Research Center for Beijing Biochip Technology and CapitalBio Corporation. In September 2007, NERCBBT was formally certified by the NDRC as a national engineering center.
Since being founded, the NERCBBT has devoted itself to developing and offering innovative products and services for the field of integrated medicine (preventive, predictable, and personal medicine). To date, four series and more than 60 products and services with independent intellectual property rights have been developed. These mainly include biochips and related instruments, consumables, reagents, and software databases. More than 10 products are international initiatives, and some products have been exported to more than 30 countries and regions. As a leading corporation and research organization of the biochip industry in China, the NERCBBT has been identified as a commercialization base for achievements of the national high-tech R&D program of China, a national IPR pilot unit in enterprises and public institutions, a national educational base of life science and technology, a post-doctoral scientific research workstation, and a science & technology research and development institution in Beijing. Additionally, the NERCBBT has been the host of the China Medical Biotech Association Biochip Branch and the secretariat for the National Technical Committee on Biochips of the Standardization Administration for China.
With first-class research facilities, sound production conditions, a strong scientific atmosphere, and a group of senior researchers that are internationally famous in the field of biochip technology, the NERCBBT is a world leader for the research, development, and industrialization of biochips.
Since being founded, the NERCBBT has undertaken and completed a number of major national science and technology projects, "863" projects, and other major projects. The NERCBBT has also made a number of original technology achievements with independent intellectual property rights in several key biochip technologies. The major scientific and awards are listed as follows:
In 2000, the independently developed, patented technology "Electromagnetic biochip" was named by Chinese academicians as one of "China's top ten scientific and technological progresses in 2000".
In 2008, core technology “development and applications of systematic biological chips and related equipment” was presented a second place Technology Invention Award of 2007 State Scientific & Technological Award.
Since 2006, six products (such as the LuxScan microarray scanner series, HLA genotyping chip system, and deafness gene mutation detection array kit) have been identified as national key new products.
By July 2013, CapitalBio had a total of 186 domestic and foreign patents. The patent implementation rate has reached 55%.
The NERCBBT and CapitalBio are devoted to be market-oriented and have successfully explored a "center + company" entrepreneurial innovation mode of operation in China. In addition, the continuous technological innovations and excellent transformation capabilities have brought the NERCBBT and CapitalBio into a positive circle of the development track.